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Background: Patellar luxation is an orthopedic disorder in which the patella moves out of its normal location
within the femoral trochlea of the knee and it can lead to osteoarthritis, lameness, and pain. In dogs it is a heritable
trait, with both environmental and genetic factors contributing to the phenotype. The prevalence of patellar
luxation in the Dutch Flat-Coated Retriever population is 24%. In this study, we investigated the molecular genetics
of the disorder in this population.
Results: Genome-wide association analysis of 15,823 single nucleotide polymorphisms (SNPs) in 45 cases and 40
controls revealed that patellar luxation was significantly associated with a region on chromosome CFA07, and
possibly with regions on CFA03, CFA31, and CFA36. The exons of the genes in these regions, 0.5 Mb combined,
were analyzed further. These exons from 15 cases and a pooled sample from 15 controls were enriched using
custom genomic hybridization arrays and analyzed by massive parallel DNA sequencing. In total 7257 variations
were detected. Subsequently, a selection of 144 of these SNPs were genotyped in 95 Flat-Coated Retrievers. Nine
SNPs, in eight genes on CFA07 and CFA31, were associated with patellar luxation (P <10−4). Genotyping of these
SNPs in samples from a variety of breeds revealed that the disease-associated allele of one synonymous SNP in a
pseudogene of FMO6 was unique to Flat-Coated Retrievers.
Conclusion: Genome-wide association analysis followed by targeted DNA sequencing identified loci on
chromosomes 7 and 31 as being involved in patellar luxation in the Flat-Coated Retriever breed.
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Patellar luxation (PL) is a common developmental
orthopedic disorder in dogs [1-3]. Normally, the patella
is located within the trochlea of the femur at a fixed dis-
tance from the tibial crest and has only limited sideways
movement within this groove [4]. PL occurs when the
patella moves out of the trochlear groove and it can lead
to degenerative joint disease. Although surgical correc-
tion can be performed in most cases, joint cartilage
damage may lead to osteoarthritis and consequently to
permanent pain and lameness.* Correspondence: P.A.J.Leegwater@uu.nl
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unless otherwise stated.Developmental PL is most often seen in small breed
dogs [5,6], with the prevalence of PL in breeds appearing
to decrease with increasing body size [6,7]. Both medial
and lateral PL (inward and outward movability, respect-
ively) occur in dogs, and medial PL is more common
than lateral PL in all breeds but one. Lateral PL is less
uncommon in large breed dogs than in small breed dogs
[5,6,8,9]. The one breed population where lateral PL is
more common than medial PL is the Dutch Flat-Coated
Retriever (FCR) [10]. In this population, involvement of
both hind legs of a dog occurred in half the cases and
PL was more common in female than male dogs, as has
been reported in other breeds [5,6,11]. The prevalence
op PL in Dutch FCR was 24%, much higher than the
prevalence reported for presumably mostly Americanl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Identical-by-state plot of Flat-Coated Retrievers. The
93 dogs were genotyped using arrays for 22,000 SNPs. The first two
principal components of a multidimensional identical-by-state matrix
of 45 dogs with patellar luxation (filled symbols) and 48 control
dogs that were negative for patellar luxation (open symbols) were
calculated with PLINK software. The cluster of 8 controls at the
bottom right part of the plot was excluded from further analysis.
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[www.offa.org]. In the Dutch population, lateral PL was
diagnosed in 61% of the cases, medial PL in 31% and
both lateral and medial in the remaining 8% [10].
The predisposition of certain breeds to PL and the
high proportion of dogs with bilateral PL strongly sug-
gests that PL is a heritable trait. The sex predisposition
and lack of a Mendelian segregation pattern points to
PL being a polygenic disorder [5,6]. The previously cal-
culated heritability of 0.17 in the Dutch FCR population
indicated that both environmental factors and genetic
factors play a role in the phenotypic appearance of the
trait [10]. Chromosomal regions or genes that predispose
to PL have not yet been identified.
We report on the genome-wide association analysis of
PL in the Dutch FCR population followed by massive par-
allel DNA sequence analysis and identified loci on CFA07
and CFA31 as having a major influence on the phenotype.
This is the first step toward identifying genes that are in-
volved in the development of PL and may help us gain
insight into the etiology of this crippling disorder.
Results
Genome-wide association analysis
More than 22,000 SNPs were genotyped in 45 Flat-
Coated Retrievers with signs of PL and 48 control dogs
of the same breed. In total 15,823 SNPs passed quality
control, and these were used to construct an identical-
by-state (IBS) plot, based on the first two principal com-
ponents of the multidimensional IBS matrix (Figure 1).
Eight control samples that deviated from the main popu-
lation were excluded from further analysis.
The SNP data were analyzed using two phenotypes
and two statistical approaches. A discrete case–control
phenotype was alternated with estimated breeding values
(EBVs) for individual animals. A χ2 analysis of the allele
distribution of individual SNPs in PL-positive and PL-
negative dogs indicated that PL is associated with a re-
gion on chromosome CFA07 (Figure 2A, Table 1). The
uncorrected P-value was 6.9*10−7 and the empirical P-
value after correction for multiple testing using permu-
tations of the genotype data over the groups of dogs was
1.0*10−3; the Bonferroni corrected P-value was 1.1*10−2.
Quantitative trait association analysis of individual
SNPs with PLINK software and using the EBVs of the 85
dogs instead of their PL status again indicated PL to be
associated with CFA07 (uncorrected P-value = 2.2 × 10−8)
and CFA36 (uncorrected P-value = 1.9 × 10−6). Both asso-
ciations were significant after correction for multiple test-
ing using the Bonferroni correction (Figure 2B).
Multiple SNP analysis using a Bayesian variable selec-
tion method [12], as implemented in iBay software, re-
vealed regions associated with PL (Bayesian factor > 1)
on chromosomes 3, 7, 25, 27, 31, and 36 when PL wasconsidered as a binary trait (Figure 2C, Table 1). The
region on CFA03 explained the largest part of the
phenotypic variation (Bayesian factor = 3.97). When the
EBV was used as phenotypic score, chromosomes 1 and
7 were associated with the PL phenotype (Bayesian fac-
tor >1, Figure 2D, Table 1).
Four regions of interest were selected on the basis of the
results from the individual and multiple SNP association
studies for both phenotypes. These regions included CFA03
(Canfam2 position 64-69 Mb), CFA07 (15–29.5 Mb),
CFA31 (13-21 Mb), and CFA36 (27.5-32 Mb).
Targeted massive parallel DNA sequencing
The exons of all genes in the four candidate regions
were selected for microarray-based enrichment and
DNA sequence analysis. The total size of the candidate
regions was approximately 32 Mb, and we designed en-
richment arrays that covered about 0.5 Mb. The selected
regions were sequenced in 15 individual dogs with PL
and in a pooled sample from 15 controls.
Enrichment probes could be designed for 93% of the
target DNA, so that 476,935 base pairs were represented.
Approximately 30% of the generated reads could be
mapped to the targeted regions. The average coverage in
the target regions was about 80 fold. In all, 7257 varia-
tions were observed in fragments that were covered at
least 10 times in one or more of the cases and at least
10 times in the control pool. The frequency of the reads
of the alternate alleles was used as an indication of the
Figure 2 (See legend on next page.)
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Figure 2 Genome-wide association analysis of patellar luxation in Flat-Coated Retrievers. (A) Association of individual SNPs with patellar
luxation was analyzed with PLINK software by comparing allele frequencies in the cases (n = 45) and controls (n = 40). (B) Association analysis of
individual SNPs using the Estimated Breeding Values (EBV) as phenotype using PLINK. (C) Multi-SNP association analysis was performed using the
case/control patellar luxation status and iBAY software. (D) same as (C) using EBV as phenotype. The –10log of the P-values obtained of individual
SNPs are plotted in (A) and (B), with the dotted lines indicating the Bonferroni threshold over 15,823 SNPs (α = 0.05). Multi-SNP association values
are presented as Bayes factors in (C) and (D), with the dotted lines indicating the ‘substantial’ effect threshold according to guidelines by Kass
and Raftery [19].
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tions were detected with a coverage of more than 25
reads in at least 10 cases and in the control pool. The
difference in the average allele frequency based on the
number of reads per allele between the cases and the
control pool was more than 10%. The 40 SNPs with the
largest difference in frequency between the cases and
the pool of controls are depicted in Table 2.
Genotyping of candidate SNPs in a large cohort
A set of 124 SNPs was selected for further analysis on the
basis of the differences in allele frequency between casesTable 1 Comparison of top SNPs associated with patellar luxa
value*
MAF
Chr BP SNP Cases C
1 99888625 BICF2S2314252 0.42
3 67056782 BICF2P309055 0.16
4 16996349 BICF2S23034244 0.17
7 17648777 BICF2S2293048 0.18
7 18970233 BICF2G630553500 0.12
7 19071723 BICF2P1448362 0.14
7 19746349 BICF2G630553889 0.12
7 20109002 BICF2P1333659 0.13
7 20145907 BICF2P1335550 0.13
7 21065761 BICF2S23030368 0.13
7 22157845 BICF2P233561 0.19
7 23113211 BICF2P1060266 0.12
7 24186445 BICF2P424667 0.12
7 25490867 BICF2P205579 0.23
7 27099172 BICF2S2457585 0.11
7 28293222 BICF2P1386712 0.12
7 32710038 BICF2G630555333 0.26
25 49858895 BICF2P1461096 0.24
27 43484050 BICF2G630153501 0.58
27 46605159 BICF2G630154851 0.58
31 15166531 BICF2S23135348 0.36
36 29549762 BICF2S22944651 0.51
36 29608881 BICF2G630757990 0.64
*MAF: minor allele frequency; Single-SNP associations are presented as –logp valueand controls. Because the SNPs with the greatest differ-
ence in frequency were mainly in regions on CFA07, 20
SNPs were added from regions on CFA03, CFA31, and
CFA36. The complete set of 144 selected SNPs is listed in
Additional file 1. These SNPs were genotyped in a group
of 95 FCRs. This was done to expand the dataset and to
ascertain the genotype deduced from the read coverage of
each allele. This group of dogs largely overlapped, but was
not identical to, the group used in the genome wide SNP
analysis. This was because only a limited amount of DNA
was available for 6 control dogs. These were replaced by
other controls and 10 more controls were added. In total,tion defined as binary trait or by estimated breeding
Single-SNP Multi-SNP
ontrols PL status EBV PL status EBV
0.23 2.20 2.94 0.42 1.18
0.43 4.01 2.90 3.97 0.22
0.45 4.24 4.67 0.41 0.16
0.46 4.20 2.77 0.65 0.04
0.41 4.79 4.54 0.57 0.21
0.44 4.64 4.34 0.39 0.26
0.46 6.06 4.83 1.30 0.69
0.46 5.65 4.52 1.07 0.31
0.46 5.65 4.52 1.22 0.40
0.45 5.33 4.87 0.81 0.31
0.51 5.05 4.11 0.73 0.20
0.41 4.79 5.06 0.26 0.37
0.41 4.79 5.06 0.33 0.24
0.53 4.07 3.88 0.46 0.15
0.45 6.16 7.34 1.62 8.11
0.46 6.06 7.67 1.23 5.95
0.49 2.73 5.33 0.09 0.14
0.49 3.01 3.49 1.08 0.19
0.33 3.02 1.98 1.16 0.17
0.34 2.77 2.74 1.17 0.33
0.09 4.48 3.35 1.29 0.12
0.21 4.22 5.73 1.22 0.07
0.29 5.22 5.17 1.45 0.09
s; Multi-SNP associations as Bayesian factors.
Table 2 Top 40 variations associated with patellar luxation derived from DNA sequence data
CFA Position Alleles Associated allele Frequency cases Frequency controls Frequency difference
03 67172456 [A/G] G 0.54 0.33 0.21
07 15554687 [G/A] A 0.45 0.23 0.22
07 15995236 [T/C] C 0.55 0.27 0.28
07 17387000 [A/G] G 0.53 0.31 0.22
07 19204281 [C/G] G 0.72 0.50 0.22
07 19301203 [T/C] C 0.82 0.53 0.29
07 19865384 [A/G] G 0.65 0.36 0.29
07 20790820 [T/C] C 0.42 0.16 0.26
07 21406148 [C/T] C 0.26 0.57 0.31
07 22035860 [A/G] G 0.72 0.44 0.28
07 22172500 [G/A] A 0.81 0.57 0.24
07 22173886 [G/A] A 0.84 0.49 0.35
07 22420986 [C/A] A 0.51 0.26 0.25
07 23548193 [A/G] A 0.09 0.33 0.24
07 24673491 [G/T] T 0.27 0.06 0.21
07 24704299 [C/T] C 0.12 0.46 0.34
07 25534837 [G/A] A 0.61 0.37 0.24
07 27238943 [G/A] G 0.37 0.58 0.21
07 28291838 [C/T] T 0.84 0.47 0.37
07 28294930 [T/C] C 0.66 0.31 0.35
07 29308525 [C/T] T 0.75 0.37 0.38
07 29526712 [G/T] T 0.38 0.17 0.21
07 30605944 [C/T] T 0.43 0.21 0.22
07 30605965 [G/T] T 0.39 0.15 0.24
07 31235880 [T/C] C 0.67 0.29 0.38
07 31855627 [T/C] C 0.71 0.46 0.25
07 31856484 [T/C] C 0.65 0.41 0.24
07 31859005 [T/A] T 0.16 0.44 0.28
07 32013108 [A/G] A 0.19 0.47 0.28
07 32149996 [T/C] C 0.63 0.15 0.48
07 32161825 [G/A] A 0.71 0.35 0.36
07 32162626 [T/C] C 0.62 0.27 0.35
23 22621361 [G/A] A 0.28 0.03 0.25
23 22687566 [G/A] A 0.40 0.16 0.24
31 14341470 [G/A] A 0.47 0.26 0.21
31 17088962 [G/T] T 0.71 0.50 0.21
36 27757717 [C/A] A 0.54 0.28 0.26
36 27770444 [C/T] T 0.34 0.13 0.21
36 28095751 [A/T] A 0.13 0.35 0.22
36 29133623 [T/C] C 0.54 0.33 0.21
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monomorphic. Single SNP χ2 based analysis of the
remaining 97 SNPs identified 8 SNPs on CFA07 and 1 on
CFA31 that were associated with PL (P-value < 1.0*10−4,Table 3); the SNPs associated with PL located on CFA03
and CFA36 were less significant (P-value > 1.0*10−4).
We then investigated whether the 8 SNPs on CFA07
that were associated with PL were also polymorphic in
Table 3 Intragenic SNPs associated with patellar luxation
CFA Position Alleles -logp Gene Gene ID Effect Gene description
07 27010438 G/A 5.44 TNR 490334 Synonymous Tenascin R
07 28294930 T/C 5.08 SERPINC1 480066 Synonymous Serpin peptidase inhibitor
07 28329409 T/C 4.21 KLHL20 480067 Intronic Kelch-like 20
07 30605944 G/A 4.21 FMO2 480076 Synonymous Flavin containing monooxygenase 2
07 30669327 C/T 4.32 FMO6P 490346 Synonymous Flavin containing monooxygenase 6
07 31856484 G/C 4.02 SELE 403999 Non_Synonymous Selectin E
07 32149996 C/T 5.35 BLZF1 490354 Synonymous Basic leucine zipper nuclear factor 1
07 32162626 T/C 5.09 BLZF1 490354 Intronic Basic leucine zipper nuclear factor 1
31 14864500 T/C 5.35 NRIP1 478385 Synonymous Nuclear receptor interacting protein 1
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alleles associated with PL in the FCR breed were also de-
tected in other breeds, with the exception of the syn-
onymous SNP in the FMO6 pseudogene at position
30669327, which was not common in the other breeds.
Discussion
In this study, we analyzed the susceptibility of Flat-
Coated Retrievers to PL in two ways: we used the PL
status of the animals as a binary trait (PL present or ab-
sent) and we used the EBV of all dogs as a quantitative
trait. The breeding value takes into account all available
phenotypic data from relatives and the animal itself
and is a better indicator of genetic susceptibility than an
animal’s disease status alone. The observation that the
EBV approach resulted in more significant P-values than
the binary trait approach illustrates the usefulness of the
EBV approach, indicating that a region on CFA07 is
involved in the development of PL. The level of signifi-
cance obtained for this complex disorder using a rela-
tively low number of cases and controls suggests that
this region is a major determinant of PL. The choice of
DNA sequencing strategy was influenced by two consid-
erations. First, there was the large size (9 Mb) of the re-
gion on CFA07 associated with PL. By choosing an exon
sequencing strategy, not only could the entire associated
region on CFA07 be included, but also additional regions.
Second, the number of DNA samples that could be se-
quenced was limited by the small number of DNA bar-
code addresses available when the study was performed.
Only 30% of the reads mapped to the targeted chromo-
somal regions instead of the minimally expected 60% (19).
We have no explanation for this low yield of the used en-
richment procedure with genomic hybridization arrays. In
unrelated projects, we obtained higher yields with in solu-
tion enrichment protocols.
We pooled control samples because we thought that
the allele frequency of DNA sequence variants could be
established on the basis of their representation in the
reads. However, analysis of individually sequenced DNAof the cases indicated that with an average coverage of
80 reads the allele representation was highly variable
and therefore an unreliable indicator of the underlying
genotype. The availability of more barcodes since then
means that the use of pooled DNA samples can be
avoided in future studies.
Approximately 25% of the SNPs genotyped using the
KASPar assay were monomorphic, which highlights the
importance of confirming Next Generation Sequencing
results using independent methods.
The function of the extensor mechanism of the stifle
joint depends on the proper alignment of the skeletal
and soft tissue elements involved, and different anatom-
ical abnormalities that cause malalignment of these ele-
ments have been suggested to be the basis of PL.
Ventro-dorsal radiographs of the hip and knees of eight
Dutch FCRs with PL did not show signs of bony mala-
lignment [Lavrijsen, unpublished data], and therefore the
involvement of muscles or ligaments in PL seems more
likely, as suggested by others [13].
We identified nine DNA sequence variants in eight
positional candidate genes for PL in affected dogs. One
of these, TNR coding for tenascin R, is a candidate gene
for PL, because mutations in one of its paralogues,
TNXB, are known to cause Ehlers-Danlos syndrome type
III in humans (omim:130020). Ehlers-Danlos syndrome
is a connective tissue disorder that is characterized by
skin hyperextensibility, articular hypermobility, and tis-
sue fragility. In humans, several disease-causing muta-
tions have been identified in genes involved in the
development and maintenance of connective tissue.
Ehlers-Danlos syndrome type III is associated with re-
current dislocation of the shoulder joint, the temporo-
mandibular joint, and the patella, without any skeletal
deformity. The associated synonymous variant in the
tenascin R gene on dog CFA07 could affect the expres-
sion of the gene by disturbing the splicing machinery
or decreasing the stability of the mRNA. In combination
with other genetic risk factors, this variant might pre-
dispose Flat-Coated Retrievers to PL. However, studies
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brain [14], which is not compatible with its involvement
in PL.
It should be noted that although we achieved an aver-
age coverage of between 80–90 DNA sequence reads
per location, not all target regions were covered suffi-
ciently. It is therefore possible that we missed relevant
mutations. In addition, as we only analyzed exons and
intron/exon boundaries, we cannot rule out that variants
in promoter regions or introns contribute to the pheno-
type. To confirm the involvement of tenascin R in PL in
Flat-coated Retrievers, the TNR gene needs to be ana-
lyzed in a replication cohort of cases and controls. Inves-
tigation of the gene in other breeds predisposed to PL
may also lead to confirmation of its role. Additional
fine-mapping of the other regions on chromosomes 3,
31, and 36 associated with PL may identify more genetic
factors involved in the disorder.
Conclusions
We identified regions on chromosomes 3, 7, 31, and 36
that are associated with PL in the Dutch Flat-Coated Re-
trievers. Fine-mapping of the region on CFA07 that
showed the strongest association led to the identification
of a synonymous variant of TNR coding for tenascin R.
Mutations in the related protein tenascin XB are the cause
of joint dislocations in humans. Follow-up is needed to
confirm the involvement of the CFA07 region in PL in the
Flat-Coated Retriever and possibly other breeds.
Methods
Animals
The animals used in this study were part of a FCR co-
hort (n = 3835) that had been screened for PL as adults
between 1990 and 2007. The dogs were investigated in
standing position and in lateral recumbency to control
the location of the patella and the possibility to luxate or
reposition the patella to grade the movability as intro-
duced by Putnam [15], Grade 0: patella is moving inside
the trochlear groove and cannot be manually luxated;
grade ‘loose’: patella can be manually positioned on the
ridge of the trochlear groove but cannot be positioned
out of the groove; grade 1: manually luxatable patella
with spontaneous repositioning; grade 2: spontaneous
luxation with repositioning upon active extension of the
stifle; grade 3: constant spontaneous PL which can be
manually reduced; grade 4: constant PL which cannot be
manually reduced. All dogs included in this study have
been graded by a single board certified veterinary ortho-
pedic specialist (FJM) who made use of the above men-
tioned grading system and included grade ‘loose’ in the
group of grade 0, both referred to as ‘PL-negative’.
Pedigree records were available of 3324 of the pheno-
typed dogs. These were sired by 398 sires and 678 dams.There were 283 grandfathers and 416 grandmothers of
the phenotyped animals. An estimated breeding value
(EBV) was calculated for those dogs for which pedigree
information was available as described previously [10].
The average EBV for 723 cases was 1.71 (ranging from
−2.0 to 6.9) and the average EBV in 2600 controls was
−0.45 (ranging from −2.7 to 3.5). We calculated EBVs
using all dogs and then chose the dogs to be included
based on a high or low EBV and their relationship with
other dogs in the sample. Selected dogs with a high EBV
did not share parents as did the dogs with a low EBV. In
the 93 dogs used for genotyping, the average EBV in the
45 cases was 1.96 (ranging from 0.2 to 4.6) and the aver-
age EBV in the 48 controls was −1.37 (ranging from
−2.7 to 3.5). The dogs used for genotyping were selected
on the basis of their PL status, relatedness to other af-
fected dogs, and their EBV. Of the 45 cases, 40 had PL
grade 1 (manually luxable patella with spontaneous re-
positioning), and 5 had PL grade 2 (spontaneous lux-
ation with repositioning upon active extension).
The Dutch FCR Breeders Club provided the addresses
of the dog owners, who were contacted by letter, which
was also written on behalf of the Breeders Club, to in-
form them about the project and with the request that
they ask their licensed veterinarian to take a 4 ml blood
sample from their dog for DNA isolation. The samples
were forwarded by the veterinarians. All dogs were pri-
vately owned and owneres provided informed consent.
The study complied with the conditions of the Dutch
‘Wet op de Uitoefening van de Diergeneeskunde’ (Law
on the Practice of Veterinary Medicine) of March 21,
1990. Approval by an ethics committee for the use of
the blood samples was not necessary.
Genotyping and data analysis
DNA was isolated from the samples collected from the
45 PL-positive and 48 PL-negative dogs, using a stand-
ard salt extraction method [16]. The Illumina Cani-
neSNP20 BeadChip with approximately 22,000 single
nucleotide polymorphisms (SNPs) was used to genotype
the 93 dogs. Only SNPs that had a minor allele fre-
quency of more than 1% and that were genotyped in
more than 90% of samples were included in the further
analysis. PLINK software [17] was used to calculate an
identical-by-state matrix between all 93 samples.
Single SNP association analyses were conducted using
both the PL status of the animals as a binary trait and
the EBV of the animals as a quantitative trait. A χ2 based
allelic association analysis with 45 cases and 40 controls
was performed, as well as linear regression modeling
using the EBVs of the cases and controls. The sex of the
animal was included as a covariate in the linear regres-
sion. Both analyses were carried out using PLINK v1.07
software [17]. A Bonferroni correction was applied to
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0.05 as the threshold for significance (P-value <1*10-5.5).
Permutations were also performed (EMP2, n = 1000) as
a less stringent method than the Bonferroni correction
to correct for multiple testing.
The multiple SNP association analysis was based on a
Bayesian variable selection method using iBay software
[12,18]. To detect associated regions, we used a model
that included a polygenic effect as well as all SNPs sim-
ultaneously. A priori a mixture model was used, which
assumed that all SNPs belonged to one of two normal
distributions: the first distribution contained SNPs with
little to no effect on the phenotype (most the SNPs were
included in this category), and the second distribution
contained the few SNPs that did affect the phenotype.
Underlying assumptions about the properties of the two
distributions were: (1) the first distribution contained
95% or more of all SNPs and the second contained less
than 5%; and (2) the first distribution explained 0.5% of
the phenotypic variation observed while the second ex-
plained 99.5%. Analogous to the computation and use of
the Bayes Factor between two models, we used a ‘param-
eter-wise Bayes Factor’ (BF) as the odds ratio between
posterior and prior probabilities for an individual marker
to be in either of the two distributions. According to
Kass and Raftery [19], a BF value higher than 3.2 is con-
sidered ‘substantial’, a BF value higher than 10 as ‘strong’,
and a BF value higher than 100 as ‘decisive’.
Targeted enrichment of genomic DNA fragments and
massive parallel sequencing
DNA samples from 15 cases and 15 controls were purified
using phenol/chloroform extraction and ethanol precipita-
tion by standard techniques, and the DNA concentration
was measured using Qubit® (Invitrogen). DNA from the
15 cases was individually sequenced (1 μg/sample). Equal
amounts of DNA from the control dogs were pooled and
1 μg of pooled DNA was used. The 15 individual samples
and the pooled sample were sheared by sonication, under-
went end-repair and phosphorylation steps, and then
adaptors containing barcode addresses were ligated to the
resulting fragments and nick translated as described [20].
Fragments were purified, amplified, and hybridized to a
custom designed Agilent® Comparative Genomic Hybrid-
isation Microarray. This array was designed to capture all
coding exons including 20 bp flanks in the four candidate
regions (CanFam2, ensemble57) as well as in the genes
COL15A1, THRB1, COL6A3, FGF6, FGF23, and WNT5B.
The captured DNA fragments were sequenced using the
SOLiD version 4 system. Array design, library preparation,
enrichment hybridization and elution, SOLiD sequencing,
and mapping of the DNA sequence data were performed
at the Hubrecht Institute (Utrecht, the Netherlands) as de-
scribed [20,21].Genotyping of DNA sequence variations
We genotyped selected variations detected by DNA se-
quencing in 95 FCRs, using the Komparative Allele Spe-
cific PCR (KASPar) assay (KBioscience, Hoddesdon,
UK). Two differently labeled allele-specific primers and
a common reverse primer were designed for each vari-
able position. Oligo extension PCR in the presence of
universal fluorescent reporting dyes, in combination
with the fluorescence resonance energy transfer (FRET)
technique, makes it possible to determine the distribu-
tion of the two alleles in the PCR product. Kluster Caller
software (KBioscience, Hoddesdon, UK) was used to de-
termine the genotypes.
The multi-breed sample set contained material from 24
different breeds, 4 samples from English Cocker Spaniels,
American Cocker Spaniels, Cavalier King Charles Spaniels,
West Highland White Terriers, Cairn Terriers, Border
Terrier, Airedale Terriers, Welsh Corgis, Kooikerhondjes
(Small Dutch Waterfowl Dog), Basset Hounds, Miniature
Schnauzer, Giant Schnauzers, Wetterhouns (Frisian Water
Dog), Irish Setters, German Short-haired Pointing Dogs,
Dobermanns, Boerboels, Bloodhounds, German Shepherd
Dogs, Dutch Shepherd Dogs, Golden Retrievers, Labrador
Retrievers, Bernese Mountain Dogs, and 3 samples from
Chesapeake Bay Retrievers. The previously described
KASPar assay was used to determine genotypes.
Availability of supporting data
SNP data obtained with microarrays are available in the
ArrayExpress database under accession number E-MTAB-
2040 [22].
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Additional file 1: Evaluation of DNA sequence variations in
Flat-Coated Retrievers. Excel table (.xlsx) showing allele frequencies of
144 selected SNPs in 95 Flat-Coated Retrievers.
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